INS and type 2 diabetes mellitus: T2D is classically described as a heterogeneous group of disorders, characterized by a decline in insulin-producing pancreatic β cells, an increase in peripheral insulin resistance, an increase in hepatic glucose production, or a combination of all the factors (Alejandro et al., 2015).